Parathyroid Disorders Market Size, Application And Trends Analysis By Type (Hyperparathyroidism, Parathyroid Cancer, Hypoparathyroidism), Diagnosis (Blood Test, Imaging, Urine Test), Treatment (Surgery, Radiation Therapy, Drugs), End User – Global Forecast Till 2023
Market Highlights:
It is estimated that the parathyroid disorders market size is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023. Parathyroid hormone plays a significant role in regulating the metabolism of calcium, phosphate, and Vitamin D. The hyperparathyroidism, and hypoparathyroidism are the two most common parathyroid disorders.
A number of factors such as growing geriatric population, rising prevalence of parathyroid disorders, increasing government assistance, rising healthcare expenditure, improving regulatory framework, and rising funding and reimbursements are propelling the growth of the global parathyroid disorders market.
However, challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs, expiration of patented drugs, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
Segmentation
The global parathyroid disorders market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of the type, the market is classified as hyperparathyroidism (HPT), parathyroid cancer, and hypoparathyroidism. The hyperparathyroidism is further sub-segmented into primary hyperparathyroidism, secondary hyperparathyroidism, and tertiary hyperparathyroidism.
On the basis of the diagnosis, the market is classified as blood tests, imaging tests, and urine tests. The imaging tests is further sub-segmented into CT or CAT (computed axial tomography) scans, MRI (magnetic resonance imaging) scans, X-ray, ultrasound, bone density test, and sestamibi scan.
On the basis of the treatment, the market is classified as surgery, radiation therapy, drugs, and others. The drugs segment is further sub-segmented into calcimimetics, hormone replacement therapy, and bisphosphonates.
On the basis of the end user, the market is segmented into hospitals & clinics, diagnostic centers, drug stores, pharmacies, and others.
Key Players
Some of the key players in the global parathyroid disorders market are Abbott Laboratories, Alcon Laboratories, Inc., Amgen Inc., Bayer Healthcare, Becton, Dickinson and Company, Eli Lilly, Ethicon, Inc., Genentech, Medtronic, Merck, Mylan Laboratories, Novartis, Novo Nordisk, Pfizer, Roche, Smith & Nephew plc, Stryker, Teva Pharmaceutical Industries Ltd., Zimmer Biomet Holdings, Inc., and others.
Regional Analysis:
The Americas dominate the global parathyroid disorders market owing to the rising prevalence of parathyroid disorders and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total healthcare expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.
Europe holds the second position in the parathyroid disorders market. It is expected that the support provided by the government bodies for research & development and improvement in the reimbursement policies in the healthcare is likely to drive the market of the European region.
The Asia Pacific is the fastest growing parathyroid disorders market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total healthcare expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.
The Middle East & Africa holds the least market share due to lack of technical knowledge and poor medical facilities.
Browse More Healthcare Related Research Reports at:
Nystagmus Market Size, Application | Dynamics, 2023
Pediatric Neurology Devices Market Research Report- Forecast to 2023 | MRFR
Asia Pacific Lancet and Pen Needles Market – Forecast to 2023 | MRFR
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: [email protected]
Market ScenarioThe Global Blood Glucose Monitoring Market is predicted to register 10.7% CAGR during the forecast period (2017-2023) owing to the increased diabetic population across the globe, asserts Market Research Future (MRFR).
Blood Glucose Monitoring is referred to as the process of testing diabetes level in the blood which helps to identify the glucose level in the blood within a specific target range.Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4921The various blood glucose monitoring devices available in the market are termed as blood glucose meter.
These devices offer useful insights to manage diabetes and helps in tracking the progress of treatment goal.
Moreover, physical inactiveness and unhealthy diet has further contributed to the market growth.Increasing awareness of diabetes, development of new technologies, and rising investment in research and development activities have fueled the market growth during the appraisal period.
Huge surge in the geriatric population and rising product launch and approvals are further influencing the market growth.On the flip side, high cost associated with the monitoring and diagnosis of diseases is one of the major concerns considered to impede the market growth in the coming years.Moreover, product recalls coupled with inadequate reimbursements are some of the factors presumed to dampen the market growth to an extent.Global Blood Glucose Monitoring Market: Segmental AnalysisThe Global Blood Glucose Monitoring Market has been segmented on the basis of application, product type, end-user, and region.By mode of product type, the global blood glucose monitoring market has been segmented into continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, flash glucose monitoring devices, and others.By mode of application, the global blood glucose monitoring market has been segmented intotype 1 diabetes, type 2 diabetes, and others.Type-I and type-II diabetes are further sub-segmented into pediatrics and adult.
The rising prevalence of type-II diabetes is fueling the growth of the use of blood glucose monitoring system.By mode of end-users, the global blood glucose monitoring market has been segmented intohospitals, diagnostic centers, research centers, clinics,and home care diagnostics.
Market HighlightsSturge-Weber syndrome is a neurological disorder characterized by a distinctive port-wine stain (PWS) on the forehead, or scalp.
PWS is a birthmark caused by an overabundance of blood capillaries near the surface of the skin.
A number of factors such as technological advancements, increasing awareness among people, increasing government assistance, improvement in the regulatory framework, and rising funding and reimbursement are propelling the growth of the global Sturge-Weber syndrome market.
Centene Corporation, a publicly traded company, has introduced clinical policy or criteria for Occipital Nerve Stimulation for Headache.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/5097However, challenges in research and development, the high cost of treatment, and poor healthcare system in the low and middle-income countries may hamper the growth of the market.
According to the Epilepsy Foundation of Greater Chicago, it is observed that VNS therapy costs approximately USD 20,000, and costs of surgery vary in different parts of the world and may increase over time.It is estimated that Sturge-Weber syndrome market is expected to grow at a healthy CAGR of 6.8% during the forecast period 2017-2023.Regional AnalysisThe Americas dominate the Sturge-Weber syndrome market owing to the rising awareness among people, and high healthcare expenditure.
According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.Europe holds the second position in the global Sturge-Weber syndrome market.
Pain can be frustrating and debilitating and can interfere with activities, time with family and friends, work, and sleep.
This covers a huge spectrum of conditions such as post-operative pain, sciatica, neuropathic pain, and others.The global chronic pain treatment market is predicted to grow at a 6.0% CAGR over the forecast period (2018-2023), as per the latest Market Research Future (MRFR) report.Various factors are propelling the chronic pain treatment market growth.
These factors, as stated by the MRFR report, include increasing technological advancements, rising prevalence of cancer pain, improved reimbursement policies, especially in developed countries, and improving regulatory framework.
Additional factors boosting market growth include increasing government assistance, rising competition between market players, unmet medical needs, and growing research funding.Avail FREE sample at: https://www.marketresearchfuture.com/sample_request/5975On the contrary, poor healthcare systems, lack of trained or skilled physicians, and high cost associated with technology in middle and low-income countries are factors that are likely to impede the chronic pain treatment market growth over the forecast period.Key PlayersLeading players profiled in the chronic pain treatment market report include –Teva PharmaceuticalsStryker CorporationSanofiPurdue Pharma LPNovartis AGMerck & Co. Inc.Nevro Corp.Dickinson and CompanyBectonNeurotech Na Inc.Braun Melsungen AGSmiths MedicalHalyard Health Inc.Pfizer Inc.Boston Scientific CorporationJude Medical Inc.Medtronic PLCMallinckrodt plcJohnson & Johnson Services Inc.GlaxoSmithKline plcForest LaboratoriesHoffmann-La Roche LtdEndo Health SolutionsEli Lilly & CompanyDJO Global LLCCodman And Shurtleff IncBayer AGAstraZeneca plcAstellas PharmaAllerganAbbvieAbbott LaboratoriesMarket SegmentationThe Market Research Future report provides a wide segmental analysis of the chronic pain treatment market based on end user, mode of purchase, indication, type of pain management drugs, and type of pain management devices.Based on pain management devices, the chronic pain treatment market is segmented inti ablation devices, analgesic infusion pumps, and neurostimulation devices.
Of these, the neurostimulation segment will have the largest share in the market over the forecast period.Based on the type of pain management drugs, the chronic pain treatment market is segmented into antidepressants, antimigraine agents, opioids, anesthetics, anticonvulsants, non-steroidal anti-inflammatory drugs (NSAIDS), and others.
The opioids segment is again segmented into methadone, meperidine, fentanyl, codeine, tramadol, hydrocodone, oxycodone, and others.Based on indication, the chronic pain treatment market is segmented into post-operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia, musculoskeletal pain, facial pain, cancer pain, neuropathic pain, and others.
Evans syndrome Market Information: by diagnosis (blood test, bone marrow biopsy, antibody assays, computed tomography (CT) scan, flow cytometry), treatment (Splenectomy, Pharmacologic, Biologic therapy, Stem Cell), end user – Global forecast till 2027Market HighlightsEvans syndrome is a rare autoimmune disorder in which the body’s immune system produces antibodies that destroy red blood cells (RBCs), platelets and sometimes white blood cells (WBCs) known as neutrophils.
Major symptoms associated with Evans syndrome include jaundice, bloody nose, fever, weakness, bacterial infections and many others.A number of factor such as rising prevalence of autoimmune disorders, increasing awareness, improving regulatory framework, increasing government assistance, increasing automation of laboratories, and rising funding and reimbursement policies are propelling the growth of the global Evan syndrome market.However, challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs and poor healthcare system in low and middle-income countries may hamper the growth of the market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5136It is estimated that the Evans syndrome market is expected to grow at a CAGR 10.2% during the forecast period of 2017-2023.Regional AnalysisThe Americas dominate the Evans syndrome market owing to the rising awareness among people, and high healthcare expenditure.
According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.Europe holds the second position in the Evans syndrome market.
It is expected that the support provided by the government bodies for research & development and improvement in reimbursement policies in the healthcare is likely to drive the market of Europe region.The Asia Pacific is the fastest growing Evans syndrome market owing to a huge patient pool and developing healthcare technology.
Healthcare expenditure is also improving in various Asia Pacific countries.
According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.The Middle East & Africa holds the lowest market due to lack of technical knowledge and poor medical facilities.SegmentationThe global Evans syndrome market is segmented on the basis of diagnosis, treatment, and distribution channels.On the basis of the diagnosis, the market is classified as blood test, bone marrow biopsy, antibody assays, computed tomography (CT) scan, flow cytometry of double-negative T cells, and others.
Occlusion Devices Market Research Report: By Product (Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices, and Support Devices), by Application (Neurology and Cardiology), by End-User (Hospitals & Clinics) – Global Forecast till 2027Market HighlightsFactors such as the increasing prevalence of chronic diseases and the increasing therapeutics demand are estimated to drive the market growth during the forecast period.
The embolization devices market is sub-segmented into liquid embolic agents and tubal occlusion devices.
On the basis of application, the market is segmented into neurology, cardiology, peripheral vascular diseases, urology, oncology, gynecology, and others.
On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, surgical centers, ambulatory care centers, and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5934Regional AnalysisThe Americas dominates the global occlusion devices market owing to the increasing prevalence of heart diseases and retinal diseases and the presence of a well-developed healthcare sector within the region.
Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region.
Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region.
Global Next Generation Contact Lenses and Visual Prostheses Market: OverviewThere are many different ways to improve or correct visions problems and no single procedure is the best solution for all the people suffering from one type of eye problem or the other.
Contact lenses and visual prostheses are such effective solutions for many.According to the findings of Brien Holden Vision Institute, an Australia-based organization with focus on eye care research, more than 130 mn people wear contact lenses across the globe.
It elucidates the opportunities, challenges, market drivers, competitive landscape, and quantitative insights to offer vital suggestions to market players on successful strategies.To know more about TMRs unique offerings for Next Generation Contact Lenses and Visual Prostheses Market, request a brochure here.Global Next Generation Contact Lenses and Visual Prostheses Market: Notable DevelopmentsGlobal next generation contact lenses and visual prostheses market has undergone key developments over the past decade, and one of these developments isJuly 2019, Paris-based Pixium Visions invented The Prima System.
The system aimed to offer vision to patients rendered blind by retinal dystrophies.The global next generation contact lenses and visual prostheses market profiles prominent market players such as Abbott Laboratories, Johnson & Johnson, Bausch & Lomb, Pixium Vision, and Bionic Sight.Global Next Generation Contact Lenses and Visual Prostheses Market: Key TrendsThe following trends, restraints, and opportunities could define the nature of the global next generation contact lenses and visual prostheses market during the review period.Rise in Ocular Diseases is Likely to Propel Growth of the MarketBlindness can be caused due to various eye diseases such as retinitis pigmentosa, macular degeneration, glaucoma, and cataract.
Such high prevalence of ocular diseases is highly likely to propel the growth of global next generation contact lenses and visual prostheses market over the assessment period.Millions of patients are either blind or gradually losing their eyesight owing to age-related macular degeneration (AMD) and retinal degenerative diseases.
Nevertheless, it holds immense promise for restoring vision to many different cases of blindness.Global Next Generation Contact Lenses and Visual Prostheses Market: Geographical AnalysisNorth America, South America, Europe, Middle East and Africa, and Asia-Pacific (APAC) are the major regions of the report on global next generation contact lenses and visual prostheses market.North America holds a large chunk of the market share owing to the surge in eye diseases, concentration of leading market players in the region and better awareness about ocular diseases.
